Tvardi Therapeutics Cash Flow Statement (2013-2025) | TVRD

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-23.30M	-30.75M	-1.01M	-33.38M	-27.91M	-4.47M	-23.84M	-31.31M	-27.65M	-32.34M	-28.90M	-32.61M	-29.67M	-6.97M	-5.51M	-10.67M	-2.39M	-8.49M	-5.53M	-7.28M
Share-based Compensation (Quarter)	4.13M	0.10M	0.58M	8.78M	5.70M	0.11M	1.72M	3.80M	3.35M	1.45M	1.39M	3.60M	3.35M	0.08M	0.08M	0.08M	1.43M	0.63M	0.34M	0.35M
Gains from Sales and Divestitures (Quarter)	0.04M	0.04M		0.21M	0.01M	0.02M	0.01M	0.01M	0.08M				0.00M	0.36M	0.01M	0.03M	792.00
Gains from Investment Securities (Quarter)	0.07M	6.00M	5.97M	0.90M	7.43M	0.01M	7.65M	0.64M	8.99M			0.66M		0.00M			0.11M	1.22M	0.10M
Asset Writedowns and Impairment (Quarter)														1.49M	1.02M	1.76M
Cash from Restructuring (Quarter)																0.44M
Non-cash Items (Quarter)	3.38M	3.64M	3.86M	4.12M	4.36M	4.69M	4.76M	3.03M	5.13M	4.39M	4.58M	4.84M	4.83M	3.80M	2.28M	2.91M	0.06M	0.76M	0.69M	0.70M
Cash from Operations (Quarter)	-23.72M	-21.00M	-14.12M	-1.25M	-25.52M	-4.50M	-25.19M	-23.51M	-34.62M	-20.45M	-19.64M	-17.37M	-30.45M	23.64M	-6.66M	-4.83M	-4.69M	-8.87M	-4.26M	-5.68M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.19M	-0.19M	-0.21M	-0.27M	-0.29M	-0.24M	1.58M	0.37M	0.38M	-0.32M	1.17M	-0.82M	0.27M	0.27M		0.22M			0.03M	0.03M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.08M	0.04M	0.01M	0.02M	0.02M		0.05M	0.02M	0.02M
Change in Working Capital
Change in Receivables (Quarter)	1.69M	-1.94M	20.05M	-19.89M	2.50M	-2.48M	9.61M	-9.58M	-0.00M	6.87M	-5.68M	-1.68M	-1.05M	1.26M	-2.54M	-0.03M	0.82M
Change in Inventory (Quarter)					-0.68M	1.55M	-1.62M	0.55M	1.13M	-0.10M	-0.15M	-0.45M	-0.08M	0.39M	0.00M	0.73M
Change in Accured Expenses (Quarter)	-2.00M	-1.39M	0.32M	2.05M	0.64M	2.83M	6.98M	-4.78M	-6.32M	9.25M	-2.90M	3.24M	-10.15M	12.73M	-1.62M	4.61M	-2.77M	2.90M	0.79M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)	0.94M	-4.72M	234.00	4.22M	0.02M	0.07M	0.19M	15.05M	-0.46M	1.14M	1.33M	-6.83M	0.28M	1.74M	3.37M	-1.19M	1.06M	-1.11M	-0.03M	0.38M
Investing Activities
Capital Expenditures (Quarter)					0.04M							1.57M	0.84M	0.21M
Sales of Property, Plant and Equipment (Quarter)	0.07M
Change in Acquisitions & Divestments (Quarter)	8.03M	1.00M	1.00M		44.00M			58.25M	29.50M	42.77M	46.33M	36.85M	59.00M	15.50M	2.50M	5.00M			5.35M	5.00M
Cash from Investing Activities (Quarter)	13.87M	20.53M	14.43M	-53.58M	33.43M	29.68M	21.18M	44.42M	17.71M	32.80M	23.16M	-30.20M	25.95M	15.29M	2.50M	5.00M			5.35M	5.00M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)	0.69M	0.29M	0.34M	45.29M	0.00M	0.18M	0.10M	0.02M	0.56M		1.12M	36.48M	-0.69M	0.69M	-0.01M	27.01M	1.01M	22.02M	-0.32M	0.00M
Additional items
Change in Cash (Quarter)	-9.16M	-0.18M	0.66M	-9.54M	7.91M	25.36M	-3.91M	20.93M	-16.35M	12.36M	4.63M	-11.10M	-5.19M	-1.62M	-6.67M	22.18M	-3.69M	-7.28M	0.77M	-0.68M
Free Cash Flow (Quarter)	-23.72M	-21.00M	-14.12M	-1.25M	-25.57M	-4.50M	-25.19M	-23.51M	-34.62M	-20.45M	-19.64M	-18.94M	-31.29M	23.43M	-6.66M	-4.83M	-4.69M	-8.87M	-4.26M	-5.68M
Net Cash Flow (Quarter)	-9.16M	-0.18M	0.66M	-9.54M	7.91M	25.36M	-3.91M	20.93M	-16.35M	12.36M	4.63M	-11.10M	-5.19M	39.62M	-4.17M	27.18M	-3.69M	13.15M	0.77M	-0.68M

Research Tools

Tvardi Therapeutics Cash Flow Statement (2013-2025) | TVRD

Create an account

Sign In

Reset Password